NCT07256145 Comparison Between the Efficacy of Ultrasound-guided Erector Spinae Plane Block and Conventional Treatment for Pain Management in Patients With Post-herpetic Neuralgia
| NCT ID | NCT07256145 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Alexandria University |
| Condition | Post-Herpetic Neuralgia |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-08-01 |
| Primary Completion | 2026-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2025-08-01 with a primary completion date of 2026-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The present study aims to evaluate the efficacy of ultrasound-guided erector spinae plane block with steroids to relieve pain in cases of post-herpetic neuralgia, patient satisfaction, and record any complications post-injection.
Eligibility Criteria
Inclusion Criteria: * Patients with post-herpetic neuralgia not responding to medical treatment. Exclusion Criteria: \- 1- Patient refusal 2- Age less than 20 years or older than 70 years. 3- Systemic Infection. 4-Patients with dementia or other diseases that could have impaired their memory or cognitive function. 5- Immunocompromised patients, severe osteoporosis, and uncontrolled diabetes mellitus.
Frequently Asked Questions
Who can join the NCT07256145 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 70 Years, studying Post-Herpetic Neuralgia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07256145 currently recruiting?
Yes, NCT07256145 is actively recruiting participants. Visit ClinicalTrials.gov or contact Alexandria University to inquire about joining.
Where is the NCT07256145 trial being conducted?
This trial is being conducted at Alexandria, Egypt.
Who is sponsoring the NCT07256145 clinical trial?
NCT07256145 is sponsored by Alexandria University. The trial plans to enroll 60 participants.